[1]
Dr. Anil Kumar Muthineni, “FRACTURE RISK ASSOCIATED WITH ORAL CORTICOSTEROID USE: A RETROSPECTIVE COHORT STUDY ON DOSE-RESPONSE AND THE REVERSIBILITY OF FRACTURE RISK POST-THERAPY”, J Popl Ther Clin Pharmacol, vol. 28, no. 2, pp. 1206–1213, Dec. 2021, doi: 10.53555/22stae90.